Amylin Pharmaceuticals, Inc. (AMLN), Eli Lilly and Company (LLY)'s Byetta May Have Cancer Risk, FDA Says  
4/12/2010 11:28:01 AM

April 9 (Bloomberg) -- Amylin Pharmaceuticals Inc. and Eli Lilly & Co.’s long-acting Byetta may be tied to increased cancer risk, a top U.S. regulator said, raising concerns that the experimental diabetes drug may need strict warnings.